Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
Journal of Neurology|September 21, 2004
Is multiple sclerosis a disease that requires frequent beta interferon dosing?Luca DurelliJournal of Neurology|January 9, 2004
Dose and frequency of interferon treatment matter--INCOMIN and OPTIMSLuca DurelliJournal of Neurology|September 20, 2005
The importance of maintaining effective therapy in multiple sclerosisLuca Durelli, Marinella ClericoFrontiers in Bioscience : a Journal and Virtual Library|September 9, 2004
Anti-interferon antibodies in multiple sclerosis. Molecular basis and their impact on clinical efficacyLuca Durelli, Alessandra RicciExpert Opinion on Biological Therapy|March 22, 2007
Interferon-beta1a for the treatment of multiple sclerosisMarinella Clerico, Giulia Contessa, Luca DurelliJournal of the Neurological Sciences|March 23, 2007
Adherence to interferon-beta treatment and results of therapy switchingMarinella Clerico, Pierangelo Barbero, Giulia Contessa, et al.Clinical Neurology and Neurosurgery|January 1, 2008
The therapy of multiple sclerosis with immune-modulating or immunosuppressive drug. A critical evaluation based upon evidence based parameters and published systematic reviewsMarinella Clerico, Chiara Rivoiro, Giulia Contessa, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|March 15, 2017
Active CMV infection in two patients with multiple sclerosis treated with alemtuzumabMarinella Clerico, Stefania De Mercanti, Carlo Alberto Artusi, et al.Lancet (London, England)|May 4, 2002
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN)Luca Durelli, Elisabetta Verdun, Pierangelo Barbero, et al.Journal of Neuroimmunology|March 8, 2005
Immunodetection of anti-MAG IgM antibody by cross-reactivity to LA-N-1 neuroblastoma cellsGianluca Isoardo, Silvia Deaglio, Dario Cocito, et al.Pageof 4